Abstract:Abstract Since the discovery of endothelial progenitor cells (EPCs) almost 2 decades ago, there has been great hope in their use in treating chronic ischemic disease. Unfortunately, to date, many of the clinical trials using EPCs have been hampered by the lack of clear definition of this cell population. Attributes of a progenitor population are self-renewal and multipotentiality. Major progress has been achieved moving from a definition of EPCs based on a candidate cell surface molecule to a functional definition based essentially on self-renewal hierarchy of endothelial colony-forming cells (ECFCs). More recent work has seized on this functional characterization to associate gene expression signatures with the self-renewal capacity of ECFCs. In particular, Notch signaling driving the quiescence of progenitors has been shown to be central to progenitor self-renewal. This new molecular definition has tremendous translational consequences, because progenitors have been shown to display greater vasculogenic potential. Also, this molecular definition of EPC self-renewal allows assessment of the quality of presumed EPC preparations. This promises to be the initial stage in progressing EPCs further into mainstream clinical use. Significance The development of a therapy using endothelial progenitor cells provides great hope for patients in treating cardiovascular diseases going forward. For continual development of this therapy toward the clinical, further understanding of the fundamental biology of these cells is required. This will enable a greater understanding of their stemness capacity and provide insight into their ability to differentiate and drive tissue regeneration when injected into a host.

Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy.

MicroRNAs As Potential Novel Therapeutic Targets and Tools for Regulating Paracrine Function of Endothelial Progenitor Cells

Endothelial progenitor cells in age-related vascular remodeling.

Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension

Endothelial progenitor cells: precursors for angiogenesis

Endothelial Progenitor Cells and In-stent Restenosis.

Characterizations and Roles of Endothelial Progenitor Cells in Vascular Biology

Contribution of Endothelial Progenitor Cells to Neovascularization

Endothelial progenitor cells and their roles in ischemic cerebrovascular disease

Endothelial Repair by Stem and Progenitor Cells

Endothelial Progenitor Cells-Potential Targets of Drug Therapy

Concise Review: Functional Definition of Endothelial Progenitor Cells: A Molecular Perspective

Endothelial precursors in vascular repair

Endothelial Progenitor Cells in Angiogenesis.

Endothelial progenitor cell-derived extracellular vesicles: the world of potential prospects for the treatment of cardiovascular diseases

Influential Factors in Mobilization of Endothelial Progenitor Cells

Circulating endothelial progenitor cell and its application]

Progenitor cells in vascular disease.

Progenitor Cells in Vascular Disease

Endothelial progenitor cell therapy in atherosclerosis: A double-edged sword?

Vascular Repair by Endothelial Progenitor Cells